In addition, low levels of palmitic acid and stearic acid, substrates of SCD1 appeared to correlate with clinical outcomes, indicating fatty acid synthesis via ACC and FASN in the downstream of SCD1 may also be involved in the immunosuppressive conditions in patients with cancer as shown in our mouse models in this study. This evidence concerns the gene SCD and cancer.